Vontobel Holding’s Adaptive Biotechnologies ADPT Stock Holding History

Vontobel Holding’s Portfolio ADPT Stock Details ADPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$365K	Hold	17,000	–	–	﹤0.01%	1174
2026 Q1	$236K	Sell	17,000 -91	-0.5%	-$1.45K	﹤0.01%	1072
2025 Q4	$278K	Buy	17,091 +91	+0.5%	+$1.49K	﹤0.01%	1198
2025 Q3	$254K	Hold	17,000	–	–	﹤0.01%	1156
2025 Q2	$198K	Hold	17,000	–	–	﹤0.01%	1173
2025 Q1	$126K	Hold	17,000	–	–	﹤0.01%	1040
2024 Q4	$102K	Hold	17,000	–	–	﹤0.01%	1049
2024 Q3	$87K	Buy	17,000 +4,000	+31%	+$17.4K	﹤0.01%	1038
2024 Q2	$47.1K	Buy	+13,000	New	+$41.3K	﹤0.01%	1045
2022 Q1	–	Sell	-44,937	Closed	-$1.27M	–	1051
2021 Q4	$1.27M	Sell	44,937 -2,740	-6%	-$84K	0.01%	565
2021 Q3	$1.62M	Buy	47,677 +39,677	+496%	+$1.43M	0.01%	490
2021 Q2	$327K	Hold	8,000	–	–	﹤0.01%	891
2021 Q1	$322K	Hold	8,000	–	–	﹤0.01%	780
2020 Q4	$473K	Buy	+8,000	New	+$413K	﹤0.01%	666

Other funds holding ADPT

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vontobel Holding's ADPT Position: Q2 2026 in Review

Vontobel Holding held its Adaptive Biotechnologies (ADPT) position steady in Q2 2026 at 17,000 shares worth $365K. The position accounts for ﹤0.01% of the portfolio, ranked #1174.

Vontobel Holding first reported a position in ADPT in Q4 2020 and has held it in 14 quarters since. The position peaked at $1.62M in Q3 2021. 300 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

Vontobel Holding held 17,000 shares of Adaptive Biotechnologies worth $365K as of Q2 2026.
Vontobel Holding left its Adaptive Biotechnologies share count unchanged in Q2 2026.
Adaptive Biotechnologies made up ﹤0.01% of Vontobel Holding's portfolio in Q2 2026, its #1174 holding.
Vontobel Holding first reported a position in Adaptive Biotechnologies in Q4 2020 and has held it in 14 quarters since.
Vontobel Holding's Adaptive Biotechnologies position peaked at $1.62M in Q3 2021.
300 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Vontobel Holding's 13F filing for Q2 2026, filed 3 Aug 2026.